April 2 (Reuters) - Sirtris Pharmaceuticals Inc said the U.S. health regulators granted orphan drug status for resveratrol, a compound derived from red wine, to treat a fatal muscular disorder.
April 2 (Reuters) - Sirtris Pharmaceuticals Inc said the U.S. health regulators granted orphan drug status for resveratrol, a compound derived from red wine, to treat a fatal muscular disorder.
